viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 8
tüüp :
ajaleht
interneti link :
http://www.ajhp.org/cgi/content/abstract/45/2/368
uurimisrühmad :
Waukegan - Du pont Critical Care, Pharmaceutical Development Department
Autor :
Karnatz NN, Wong J, Kesler H, Baaske DM, Speicher ER.
pealkiri :
Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
publikatsioon :
Am J Hosp Pharm ; 45: 368-371. 1988
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Esmolol hydrochloride
5 mg/ml
+
Fentanyl citrate
25 µg/ml
+
5 mg/ml
+
Fentanyl citrate
25 µg/ml
+
5 mg/ml
+
Morphine sulfate
7,5 mg/ml
+
5 mg/ml
+
Morphine sulfate
7,5 mg/ml
+
Fentanyl citrate
25 µg/ml
+
Esmolol hydrochloride
5 mg/ml
+
25 µg/ml
+
Esmolol hydrochloride
5 mg/ml
+
Morphine sulfate
7,5 mg/ml
+
Esmolol hydrochloride
5 mg/ml
+
7,5 mg/ml
+
Esmolol hydrochloride
5 mg/ml
+
15°C-30°C
Esmolol hydrochloride
5 mg/ml
Morphine sulfate
7,5 mg/ml
8
15°C-30°C
Esmolol hydrochloride
5 mg/ml
Fentanyl citrate
25 µg/ml
8
Mentions Légales